GENEVA, Sept. 1 -- CHONG KUN DANG PHARMACEUTICAL CORP. (8 Chungjeong-roSeodaemun-guSeoul 03742) filed a patent application (PCT/IB2025/051745) for "COMPOUND AS PARP1 INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME" on Feb 19, 2025. With publication no. WO/2025/177150, the details related to the patent application was published on Aug 28, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KO, Moo Sung (315-20, Dongbaekjukjeon-daeroGiheung-gu, Yongin-siGyeonggi-do 16995), KIM, Il Hyang (315-20, Dongbaekjukjeon-daeroGiheung-gu, Yongin-siGyeonggi-do 16995), HAN, Younghue (315-20, Dongb...